Author

Mai N. Van

Observed names: M Van, M. N. Van, M. Van, Mai N. Van, Mai Van

Observed institutions: Erasmus MC, University of Catania, Sint Franciscus Gasthuis, Ikazia Ziekenhuis, Erasmus MC Cancer Institute, GZA Ziekenhuizen, Erasmus University Rotterdam

OpenAlex ID: A5014770720

Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells

2015 · Wendy Onstenk, Anieta M. Sieuwerts, et al. · European Urology · 237

Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients

2020 · Pauline A. J. Mendelaar, Jaco Kraan, et al. · Molecular Oncology · 67

PDF

Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer

2015 · Wendy Onstenk, Anieta M. Sieuwerts, et al. · Cancer Letters · 48

Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer

2016 · Wendy Onstenk, Anieta M. Sieuwerts, et al. · Oncotarget · 46

Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer

2019 · Bodine P.S. Belderbos, Anieta M. Sieuwerts, et al. · European Journal of Cancer · 33

AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel

2019 · Anieta M. Sieuwerts, Wendy Onstenk, et al. · Molecular Oncology · 29

PDF

Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel

2019 · Ingeborg E. de Kruijff, Anieta M. Sieuwerts, et al. · Cancers · 24

PDF

An In-Depth Evaluation of the Validity and Logistics Surrounding the Testing of AR-V7 mRNA Expression in Circulating Tumor Cells

2018 · Anieta M. Sieuwerts, Bianca Mostert, et al. · Journal of Molecular Diagnostics · 20

PDF

Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study

2025 · Lissa Wullaert, Maurice P.H.M. Jansen, et al. · EClinicalMedicine · 13

Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial

2025 · Elisabeth M. Jongbloed, Noor Wortelboer, et al. · Nature Medicine · 9

CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients

2022 · Khrystany T. Isebia, Bianca Mostert, et al. · European Journal of Cancer · 9

PDF

Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival

2023 · Noortje Verschoor, Vanja de Weerd, et al. · npj Breast Cancer · 8

PDF

Cryopreservation of Circulating Tumor Cells for Enumeration and Characterization

2016 · Sarah Nejlund, Julie Smith, et al. · Biopreservation and Biobanking · 7

Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial

2024 · Noortje Verschoor, Manouk K. Bos, et al. · Breast Cancer Research and Treatment · 4

PDF

Presurgical levels of circulating tumour DNA in patients with resectable chemotherapy-naïve colorectal liver metastases: association with multiorgan recurrence and survival in the MIRACLE cohort

2025 · Lissa Wullaert, Lotte van Leeuwen, et al. · British journal of surgery · 2

Abstract 2617: A multicenter project to test the validity and logistics surrounding the testing of AR-V7 mRNA expression in circulating tumor cells

2018 · Anieta M. Sieuwerts, Bianca Mostert, et al. · Cancer Research · 1

Abstract P1-02-02: ESR1 mutations in circulating tumor cell versus circulating cell-free DNA of metastatic breast cancer patients before first-line endocrine therapy and at progression

2017 · AM Sieuwerts, N Beije, et al. · Cancer Research · 1

Circulating Tumor Cells in Uveal Melanoma: Multi-Marker Detection and Association With Disease State

2026 · Daniel P. de Bruyn, Fabiana Lucia Bassil, et al. · Investigative Ophthalmology & Visual Science

PDF

2541eTiP A randomized, multicenter, phase II trial of docetaxel or cabazitaxel with or without darolutamide in patients with metastatic castration-resistant prostate cancer (the DAROTAXEL study)

2025 · T.C. Van Dijk, S.A. Buck, et al. · Annals of Oncology

Circulating Tumour Cells & Circulating Tumour DNA in Patients with Resectable Colorectal Liver Metastases – A Prospective Cohort Study (the MIRACLE)

2025 · Lissa Wullaert, Maurice P.H.M. Jansen, et al. · SSRN Electronic Journal

Prospective Evaluation of a Circulating Tumor Cell Sensitivity Profile to Predict Response to Cisplatin Chemotherapy in Metastatic Breast Cancer Patients

2021 · I. E. de Kruijff, A. M. Sieuwerts, et al. · Frontiers in Oncology

PDF

2575 Presence of androgen receptor splice variants in circulating tumor cells and response to cabazitaxel in castration-resistant prostate cancer

2015 · W. Onstenk, A. Sieuwerts, et al. · European Journal of Cancer

Works count: 22

Citation count: 558

H-index: 9

I10-index: 9